Finance
Cancer Prevention
Health

Enochian Biosciences

$5.70
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.44 (8.37%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell ENOB and other stocks, options, ETFs, and crypto commission-free!

About

Enochian Biosciences, Inc. engages in the development of vaccine for treatment of infectious diseases and cancer. Its pipeline consists of ENO-1001, ENO-2001, ENO-3001, ENO-4002 and ENO-4001. Read More The company was founded by Rene Sindlev on January 18, 2011 and is headquartered in Horsholm, Denmark. ENOB is listed on the OTCQB market tier. OTC market data is provided by OTC Markets Group, Inc (otcmarkets.com).

Employees
4
Headquarters
Los Angeles, California
Founded
2011
Market Cap
221.10M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
31.17K
High Today
$5.70
Low Today
$5.40
Open Price
$5.50
Volume
11.38K
52 Week High
$9.50
52 Week Low
$3.32

Collections

Finance
Cancer Prevention
Health
2018 IPO
US
North America

Earnings

Q4 2018
Q1 2019
Estimated
Actual
Available May 16, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.